Old Web
English
Sign In
Acemap
>
authorDetail
>
Jasmijn A. M. Sleutjes
Jasmijn A. M. Sleutjes
Erasmus University Rotterdam
Medicine
Internal medicine
Gastroenterology
Inflammatory bowel disease
Tofacitinib
8
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels.
2021
Alimentary Pharmacology & Therapeutics
Jasmijn A. M. Sleutjes
Jeanine E. Roeters van Lennep
Eric Boersma
Luis Menchén
Matthias Laudes
Klaudia Farkas
Tamás Molnár
N A Kennedy
Marieke Pierik
C. Janneke van der Woude
Annemarie C. de Vries
Show All
Source
Cite
Save
Citations (0)
Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management.
2021
Therapeutic Advances in Gastroenterology
Jasmijn A. M. Sleutjes
Jeanine E. Roeters van Lennep
C. Janneke van der Woude
Annemarie C. de Vries
Show All
Source
Cite
Save
Citations (0)
Effect of drug therapy on the lipid profiles of patient with inflammatory bowel disease: A systematic review and meta-analysis
2021
Atherosclerosis
Jasmijn A. M. Sleutjes
Eric Boersma
C.J. van der Woude
A. C. de Vries
J.E. Roeters van Lennep
Show All
Source
Cite
Save
Citations (0)
P292 Effect of drug therapy on the lipid profiles of patient with Inflammatory Bowel Disease: a systematic review and meta-analysis
2021
Journal of Crohn's and Colitis
Jasmijn A. M. Sleutjes
J.E. Roeters van Lennep
Eric Boersma
A. C. de Vries
C.J. van der Woude
Show All
Source
Cite
Save
Citations (0)
Ozanimod in Crohn's disease: a promising new player.
2020
The Lancet Gastroenterology & Hepatology
Jasmijn A. M. Sleutjes
Annemarie C. de Vries
C. Janneke van der Woude
Show All
Source
Cite
Save
Citations (1)
1